The Clinical Trials Section (CTS) at NRG was set up to meet the uniquely demanding needs of clinical trial research.
Research projects such as the DIAN Project, studying dominantly inherited Alzheimer’s disease, are generating rapidly applicable findings. However, in order to apply these findings to real patients, they must be studied and tracked in a clinical environment, which necessitates many more layers of security and training to protect patient data.
The Clinical Trials Section at NRG has been built on the foundation of certification in Good Clinical Practices, and manages project data on a 21 CFR Part 11-compliant version of XNAT known as XNAT CR.
Prominent projects include DIAN-TU, the therapeutic trials unit of the DIAN project.